Fibroid Mapping Reviewer Application (FMRA)— 510(k) K222683

Substantially Equivalent

Nesa Medtech Private Limited

FDA 510(k) clearance K222683 for Fibroid Mapping Reviewer Application (FMRA), Substantially Equivalent on 2023-07-17. Applicant: Nesa Medtech Private Limited.

Clearance details

Applicant
Nesa Medtech Private Limited
Product code
Code LLZ
Advisory panel
Radiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Bengaluru, IN
Download summary PDFView on FDA.gov ↗

Adverse events under product code LLZ

product code LLZ
Death
13
Total
13

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.